Financial Lp Hrt Buys 137,541 Shares of NewGenIvf Group (NASDAQ:NIVF) Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt acquired 137,541 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average cost of $0.99 per share, with a total value of $136,165.59. Following the purchase, the insider directly owned 111,885 shares of the company’s stock, valued at $110,766.15. This trade represents a -536.10% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Wednesday, May 27th, Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock. The shares were sold at an average price of $0.80, for a total value of $68,253.60.
• On Tuesday, May 26th, Financial Lp Hrt acquired 27,993 shares of NewGenIvf Group stock. The shares were acquired at an average cost of $0.92 per share, with a total value of $25,753.56.

NewGenIvf Group Trading Up 21.2%

NASDAQ:NIVF opened at $1.03 on Friday. NewGenIvf Group Limited has a 52-week low of $0.72 and a 52-week high of $1,839.00. The stock has a fifty day moving average of $1.66 and a 200 day moving average of $6.74. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million during the quarter. On average, equities analysts forecast that NewGenIvf Group Limited will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NewGenIvf Group has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.